...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A
【24h】

Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A

机译:吡啶基含吡喃基衍生物的设计,合成及生物学评价,作为甲型甲型A的神经氨酸酶有效抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Influenza A neuraminidase plays an indispensable role in the process of replication and transmission of influenza, so the neuraminidase inhibition can prevent the reproduction of the viruses therefore achieve the effect of treatment of influenza. However, drug resistance of neuraminidase inhibitors such as oseltamivir highlights the need to develop novel structural neuraminidase inhibitors. Here we explored a series of oseltamivir derivatives bearing pyridyl group. Among them, compound 23b exhibiting potent inhibitory activity against neuraminidase from H5N1 subtype was comparable to oseltamivir carboxylate. Cytopathic effect inhibition assay in MDCK cells indicated that compound 23b exerted powerful inhibitions on influenza viruses. And compound 23b were nontoxic to MDCK cells. Meanwhile, compound 23b showed high stability towards rat liver microsomes, human liver microsomes and human plasma. This research enriched the structural type of neuraminidase inhibitors. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:流感神经氨酸酶在流感的复制和透射过程中发挥不可或缺的作用,因此神经氨酸酶抑制可以防止病毒的繁殖,因此达到了治疗流感的效果。然而,奥司他韦诸如神经氨酸酶抑制剂的耐药性突出了开发新型结构神经氨酸酶抑制剂的需要。在这里,我们探索了含吡啶基的一系列奥司他韦衍生物。其中,从H5N1亚型中表现出对神经氨酰胺酶的有效抑制活性的化合物23B与Oseltamivir羧酸盐相当。 MDCK细胞中的细胞病变效应抑制测定表明,化合物23B对流感病毒产生了强烈的抑制。和化合物23b对MDCK细胞无毒。同时,化合物23b对大鼠肝微粒体,人肝微粒体和人血浆表现出高稳定性。该研究富集了神经氨酸酶抑制剂的结构类型。 (c)2019年Elsevier Masson SAS。版权所有。

著录项

  • 来源
  • 作者单位

    Wuyi Univ Sch Biotechnol &

    Hlth Sci Jiangmen 529020 Peoples R China;

    Shenyang Pharmaceut Univ Sch Pharmaceut Engn Minist Educ Key Lab Struct Based Drug Design &

    Beijing Inst Pharmacol &

    Toxicol Natl Engn Res Ctr Emergency Drug Beijing 100850 Peoples R China;

    Shenyang Pharmaceut Univ Sch Pharmaceut Engn Minist Educ Key Lab Struct Based Drug Design &

    Shenyang Pharmaceut Univ Sch Pharmaceut Engn Minist Educ Key Lab Struct Based Drug Design &

    Shenyang Pharmaceut Univ Sch Pharmaceut Engn Minist Educ Key Lab Struct Based Drug Design &

    Shenyang Pharmaceut Univ Sch Pharmaceut Engn Minist Educ Key Lab Struct Based Drug Design &

    Shenyang Pharmaceut Univ Sch Pharmaceut Engn Minist Educ Key Lab Struct Based Drug Design &

    Beijing Inst Pharmacol &

    Toxicol Natl Engn Res Ctr Emergency Drug Beijing 100850 Peoples R China;

    Wuyi Univ Sch Biotechnol &

    Hlth Sci Jiangmen 529020 Peoples R China;

    Shenyang Pharmaceut Univ Sch Pharmaceut Engn Minist Educ Key Lab Struct Based Drug Design &

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Influenza virus; Neuraminidase inhibitors; Oseltamivir analogues; 150 cavity;

    机译:流感病毒;神经氨酸酶抑制剂;Oseltamivir类似物;150腔;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号